ArticleJAMA network open2020
Association of the Coronavirus Disease 2019 (COVID-19) Outbreak With Enrollment in Cancer Clinical Trials.
Article in JAMA network open, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
60 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Impact of coronavirus disease 2019 pandemic on good clinical practice trials in oncology.Exploration of targeted anti-tumor therapy · 2023Pooled it
- COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials.Nature reviews. Clinical oncology · 2021Guideline
- Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus.Annals of oncology : official journal of the European Society for Medical Oncology · 2020Guideline
- One size does not fit all: A comparative framework for optimizing ribonucleic acid transfection across acute myeloid leukemia cell lines.Biology methods & protocols · 2026Article
- Healthcare-Seeking behavior for acute respiratory infections in a community population in Southwest China during the 2021-2023 influenza seasons.BMC infectious diseases · 2025Article
- Impact of the COVID-19 Pandemic Mitigation Strategies on Cancer Treatment Trials: A Meta-Analysis of Industry and National Cancer Institute Studies.JCO oncology advances · 2025Article
- Ethical issues and the role of the ethics committees during COVID-19 research in pandemic era: a focus on an Italian ethics committee.Frontiers in public health · 2025Article
- TBCRC 057: Survey about willingness to participate in cancer clinical trials during the pandemic.Cancer medicine · 2024Article
- Impact of the COVID-19 Pandemic on Cancer Clinical Trials: Alliance for Clinical Trials in Oncology Experience (Alliance A152022).Journal of clinical trials · 2024Article
- Enrollment Success, Factors, and Prediction Models in Cancer Trials (2008-2019).JCO oncology practice · 2023Article
- Patient recruitment into clinical studies of solid malignancies during the COVID-19 pandemic in a tertiary cancer center.Neoplasia (New York, N.Y.) · 2023Article
- Sponsor Perspectives on the Impact of the COVID-19 Pandemic on Interventional Cancer Clinical Trial Protocols and Data Quality.JCO oncology practice · 2023Article
- Impact of COVID-19 pandemic on nonpharmacological pain management trials in military and veteran healthcare settings: an evaluation informed by implementation science.Translational behavioral medicine · 2023Article
- Crisis of the Clinical Trials Staff Attrition After the COVID-19 Pandemic.JCO oncology practice · 2023Article
- Non-COVID-19 UK clinical trials and the COVID-19 pandemic: impact, challenges and possible solutions.Trials · 2023Article
- Financial toxicity among head and neck cancer patients and their caregivers: A cross-sectional pilot study.Laryngoscope investigative otolaryngology · 2023Article
- The value of a two-armed Bayesian response adaptive randomization trial.Journal of biopharmaceutical statistics · 2023Article
- The impact of COVID-19 pandemic on hospital admissions for nine diseases in Iran: insight from an interrupted time series analysis.Cost effectiveness and resource allocation : C/E · 2022Article
- Secondary Impact of the Coronavirus Disease 19 Pandemic on Patients and the Cellular Therapy Healthcare Ecosystem.Transplantation and cellular therapy · 2022Review
- Lessons from the Failure to Complete a Trial of Denosumab in Women With a Pathogenic BRCA1/2 Variant Scheduling Risk-Reducing Salpingo-Oophorectomy.Cancer prevention research (Philadelphia, Pa.) · 2022Article
Corrections and comments
- Commented on by
Authors and funding
4 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.